"Escape" Phenomenon of the Antihypertensive Therapy Efficacy

NCT05436730 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 165

Last updated 2022-06-29

No results posted yet for this study

Summary

A little attention is paid to the AHT efficacy escaping problem, which can be explained by the AHT correction simplicity and rapid achievement of the target BP level. Nevertheless, modern statistic data on the effective AH treatment described above let us assume that AHT correction is either totally absent or is untimely in case of the "escape" phenomenon development. This could be one of the main reasons for the high prevalence of ineffective AH treatment. The aim of this study is to determine AHT efficacy "escape" phenomenon timeline and its predictors in hypertensive patients.

Conditions

  • Arterial Hypertension

Interventions

DEVICE

Ambulatory blood pressure measurement device

Assessment of the 24-h blood pressure profile

DEVICE

Sphygmocor

Assessment of the arterial stiffness

DEVICE

VaSera-VS

Assessment of the arterial stiffness

DEVICE

Somnocheck

Assessment of the sleep breath disturbances

Sponsors & Collaborators

  • Federal State Budgetary Institution NATIONAL MEDICAL RESEARCH CENTRE OF CARDIOLOGY NAMED AFTER ACADE

    lead OTHER_GOV

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-29
Primary Completion
2016-12-30
Completion
2025-12-30

Countries

  • Russia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05436730 on ClinicalTrials.gov